Skip to main content

HOOKIPA Pharma Inc. (HOOK)

NASDAQ: HOOK · Delayed Price · USD
3.26
-0.22 (-6.32%)
At close: Nov 26, 2021 1:00 PM
3.22
-0.04 (-1.23%)
After-hours:Nov 26, 2021 3:02 PM EST

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year2020201920182017
Revenue
19.5811.947.630
Revenue Growth
63.99%56.53%--
Gross Profit
19.5811.947.630
Selling, General & Admin
18.0816.726.844.39
Research & Development
54.7946.3121.979.77
Operating Expenses
72.8763.0328.8114.16
Operating Income
-53.29-51.09-21.18-14.16
Interest Expense / Income
0.790.880.780.61
Other Expense / Income
-9.99-8.93-5.75-2.04
Pretax Income
-44.08-43.04-16.21-12.72
Income Tax
000.020
Net Income
-44.08-43.04-16.24-12.72
Net Income Common
-44.08-43.04-16.24-12.72
Shares Outstanding (Basic)
261811
Shares Outstanding (Diluted)
-1811
Shares Change
-1853.24%0.28%-
EPS (Basic)
-1.69-2.41-17.76-13.95
EPS (Diluted)
-1.69-2.41-17.76-13.95
Free Cash Flow Per Share
-1.63-2.45-18.75-14.49
Gross Margin
100.00%100.00%100.00%-
Operating Margin
-272.08%-427.78%-277.62%-
Profit Margin
-225.09%-360.38%-212.83%-
Free Cash Flow Margin
-212.98%-366.19%-224.77%-
Effective Tax Rate
0.00%0.00%-0.15%-0.03%
EBITDA
-39.15-39.09-14.8-11.72
EBITDA Margin
-199.89%-327.36%-193.93%-
EBIT
-43.3-42.16-15.44-12.11
EBIT Margin
-221.08%-353.04%-202.32%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).